STOCK TITAN

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Harmony Biosciences Holdings, Inc. (HRMY) announced its participation in upcoming investor conferences like Leerink Partners Global Biopharma Conference and Barclays Global Healthcare Conference. The management team will engage in fireside chats on March 11 and 12, 2024, respectively.
Positive
  • None.
Negative
  • None.

PLYMOUTH MEETING, Pa., Feb. 28, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conferences:

Leerink Partners Global Biopharma Conference 2024

  • Location: Miami
  • Fireside Chat: Monday, March 11, 2024, at 12:40 p.m. ET

Barclays 26th Annual Global Healthcare Conference

  • Location: Miami
  • Fireside Chat: Tuesday, March 12, 2024, at 3:35 p.m. ET

A webcast of the fireside chats will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com

Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-upcoming-investor-conferences-302073404.html

SOURCE Harmony Biosciences

Harmony Biosciences Holdings, Inc. (HRMY) will participate in the Leerink Partners Global Biopharma Conference on Monday, March 11, 2024, at 12:40 p.m. ET.

The Barclays 26th Annual Global Healthcare Conference for Harmony Biosciences Holdings, Inc. (HRMY) will be held in Miami.

Investors can access the webcast of the fireside chats by Harmony Biosciences Holdings, Inc. (HRMY) on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.
Harmony Biosciences Holdings Inc

NASDAQ:HRMY

HRMY Rankings

HRMY Latest News

HRMY Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Major, Manufacturing, Medicinal and Botanical Manufacturing

About HRMY

patients are at the beginning, middle, and heart of all we do. harmony biosciences, llc, is a privately-owned biopharmaceutical company. the company was established in october 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. harmony biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.